Home / Market News / $PHG

$PHG news and market catalysts

The 7 most recent market catalysts affecting $PHG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

7 catalysts 2 high impact 5 bullish 2 bearish Healthcare Technology
Aug 26, 2026 Corporate Catalyst Bullish Impact 55
Royal Philips Receives ARPA Award Of Up To $33.7M Under the U.S. HHS Autonomous Interventions And Robotics Program
Royal Philips has secured a substantial award of up to $33.7 million from the U.S. HHS ARPA-H program. This funding is specifically for expanding access to AI-enabled robotic strok…
Aug 11, 2026 Corporate Catalyst Bullish Impact 55
Philips And Exor Renew Long-Term Agreement, Keeping Governance Unchanged While Raising Shareholding Flexibility To 22%
Philips and Exor have renewed their long-term agreement, which is a continuation of their strategic partnership. The key change is that Exor can now increase its stake in Philips f…
Jul 28, 2026 Corporate Catalyst Bearish Impact 85
Philips Stock Sinks To 52-Week Low - Here's Why
Philips' stock declined despite beating Q2 earnings and sales estimates because investors focused on the underlying operational weaknesses. The company reported a 1% decline in com…
Jul 28, 2026 Corporate Catalyst Bearish Impact 85
Koninklijke Philips shares are trading lower. The company reported Q2 financial results.
The headline indicates a direct corporate catalyst: Philips' Q2 financial results. The 'trading lower' aspect confirms a negative market reaction, suggesting the results likely mis…
Jul 28, 2026 Corporate Catalyst Bullish Impact 75
Philips Reiterates 2026 Outlook, Raises Adjusted EBITA Margin To 13.5%-14.0% And Free Cash Flow To EUR 1.5B-1.7B On US Tariff Refund
Philips has reiterated its 2026 outlook but significantly upgraded its adjusted EBITA margin and free cash flow targets. This improvement is directly attributed to an approximate 1…
Jul 28, 2026 Corporate Catalyst Bullish Impact 75
Koninklijke Philips Q2 Adj. EPS $0.57 Beats $0.40 Estimate, Sales $5.068B Beat $5.040B Estimate
Koninklijke Philips announced Q2 adjusted EPS of $0.57, significantly surpassing the $0.40 analyst consensus, and sales of $5.068 billion, which also beat the $5.040 billion estima…
Jul 21, 2026 Corporate Catalyst Bullish Impact 55
Royal Phillips Receives FDA Clearance For Reusable SpO₂ Clip Sensor
Royal Philips has secured FDA clearance for a new reusable SpO₂ clip sensor, a significant development in its patient monitoring portfolio. This clearance is important because the …
 Join the waitlist for full signal validation →

New to reading filings? What an SEC 8-K is and why it moves prices

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.